Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Stock-Based Compensation 2010-2025 | NBIX

Neurocrine Biosciences annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Neurocrine Biosciences stock-based compensation for the quarter ending March 31, 2025 was $0.053B, a 18.65% increase year-over-year.
  • Neurocrine Biosciences stock-based compensation for the twelve months ending March 31, 2025 was $465M, a 7.63% decline year-over-year.
  • Neurocrine Biosciences annual stock-based compensation for 2024 was $0.196B, a 0.62% increase from 2023.
  • Neurocrine Biosciences annual stock-based compensation for 2023 was $0.194B, a 12.25% increase from 2022.
  • Neurocrine Biosciences annual stock-based compensation for 2022 was $0.173B, a 28.99% increase from 2021.
  
Neurocrine Biosciences Annual Stock-Based Compensation
(Millions of US $)
2024 $196
2023 $194
2022 $173
2021 $134
2020 $100
2019 $75
2018 $58
2017 $43
2016 $28
2015 $28
2014 $10
2013 $7
2012 $5
2011 $3
2010 $3
2009 $6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.988B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.266B 28.24
Zoetis (ZTS) United States $68.055B 25.39
Takeda Pharmaceutical (TAK) Japan $46.933B 9.34
Daiichi Sankyo, - (DSNKY) Japan $43.096B 22.09
BeOne Medicines - (ONC) Cayman Islands $29.559B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.954B 0.00
Summit Therapeutics (SMMT) United States $18.091B 0.00
Merck (MKKGY) Germany $16.498B 12.09
Shionogi (SGIOY) Japan $14.172B 14.20
United Therapeutics (UTHR) United States $13.227B 11.70
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.753B 47.41
Corcept Therapeutics (CORT) United States $7.573B 61.56
Madrigal Pharmaceuticals (MDGL) United States $6.908B 0.00
Grifols, S.A (GRFS) Spain $6.717B 0.00
Ionis Pharmaceuticals (IONS) United States $6.685B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.265B 16.01
Soleno Therapeutics (SLNO) United States $4.212B 0.00
Hypermarcas (HYPMY) Brazil $3.167B 20.83
Crinetics Pharmaceuticals (CRNX) United States $2.980B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.592B 14.02
Catalyst Pharmaceuticals (CPRX) United States $2.555B 8.95
NewAmsterdam Pharma (NAMS) Netherlands $2.360B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.014B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.825B 0.00
Ocular Therapeutix (OCUL) United States $1.767B 0.00
ARS Pharmaceuticals (SPRY) United States $1.725B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.301B 0.00
Harrow (HROW) United States $1.261B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.215B 24.30
Ardelyx (ARDX) United States $1.077B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.028B 5.55
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.004B 0.00
ProKidney (PROK) United States $0.986B 0.00
Verve Therapeutics (VERV) United States $0.982B 0.00
Dyne Therapeutics (DYN) United States $0.941B 0.00
Xeris Biopharma Holdings (XERS) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
KalVista Pharmaceuticals (KALV) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.724B 0.00
Zevra Therapeutics (ZVRA) United States $0.699B 0.00
Xencor (XNCR) United States $0.601B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.577B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Bioventus (BVS) United States $0.542B 13.75
Oruka Therapeutics (ORKA) United States $0.534B 0.00
Organogenesis (ORGO) United States $0.511B 0.00
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.477B 0.00
Aquestive Therapeutics (AQST) United States $0.399B 0.00
Savara (SVRA) United States $0.396B 0.00
Altimmune (ALT) United States $0.339B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Tonix Pharmaceuticals Holding (TNXP) United States $0.325B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.34
Nanobiotix S.A (NBTX) France $0.251B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.224B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
4D Molecular Therapeutics (FDMT) United States $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.111B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.099B 0.00
Jupiter Neurosciences (JUNS) United States $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Metagenomi (MGX) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
Avalo Therapeutics (AVTX) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00